comparemela.com

Latest Breaking News On - Orphan drug - Page 1 : comparemela.com

Tafenoquine Gets Orphan Drug Status for Acute Babesiosis

Babesiosis is an infectious disease caused by microscopic parasites, Babesia, that infect red blood cells.

Boston
Massachusetts
United-states
Tufts-medical-center
Geoff-dow
Drug-administration
Degrees-pharmaceuticals
Orphan-drug

Osteal Therapeutics Closes $50M Series D Financing to Support Approval and Commercial Launch of Lead Candidate

BioPharma

Dallas
Texas
United-states
David-thompson
Zimmer-biomet
Jjdc-inc
Osteal-therapeutics-inc
Johnson-innovation
Gideon-strategic-partners
Osteal-therapeutics
New-drug-application

Novel Antifibrotic Gets Orphan Drug Status for Idiopathic Pulmonary Fibrosis

The FDA has granted Orphan Drug designation to AGMB-447 for the treatment of idiopathic pulmonary fibrosis.

Philippe-wiesel
Drug-administration
Orphan-drug
Chief-medical-officer

Engineered B Cell Medicine Gets Orphan Drug Status for Hemophilia B

BE-101 is a potential first-in-class B cell medicine engineered to insert the human FIX gene into primary human B cells.

Joanne-smith-farrell
Drug-administration
Orphan-drug

Functional Improvement Seen With C1q Inhibitor in Guillain-Barré Syndrome

ANX005 is a C1q inhibitor that is administered intravenously and works by blocking the activation of classical complement pathway.

Bangladesh
Philippines
International-guillain-barr
Drug-administration
Research-council
Peripheral-nerve-society-annual-meeting-on
Medical-research-council
Douglas-love
Western-international-guillain-barr
Syndrome-outcomes-study
Biologics-license-application

vimarsana © 2020. All Rights Reserved.